These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1463320)

  • 1. [Antibiotic residues and digestive microflora].
    Corpet DE
    Ann Gastroenterol Hepatol (Paris); 1992 Oct; 28(5):235-8; discussion 238-9. PubMed ID: 1463320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotic residues and digestive microflora].
    Corpet DE
    Bull Acad Natl Med; 1992 Apr; 176(4):475-82; discussion 482-4. PubMed ID: 1504868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of models for testing antibiotic residues.
    Corpet DE
    Vet Hum Toxicol; 1993; 35 Suppl 1():37-46. PubMed ID: 8236756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A dynamic study of drug resistance in populations of fecal "Escherichia coli" from axenic mice, fed chlortetracycline continuously and associated with flora from infant, calf and piglet (author's transl)].
    Corpet D
    Ann Microbiol (Paris); 1980; 131B(3):309-18. PubMed ID: 7008675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of residual and therapeutic doses of tetracycline in the human-flora-associated (HFA) mice model.
    Perrin-Guyomard A; Cottin S; Corpet DE; Boisseau J; Poul JM
    Regul Toxicol Pharmacol; 2001 Oct; 34(2):125-36. PubMed ID: 11603955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human studies to measure the effect of antibiotic residues.
    Elder HA; Roy I; Lehman S; Phillips RL; Kass EH
    Vet Hum Toxicol; 1993; 35 Suppl 1():31-6. PubMed ID: 8236755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vivo plasmid transfer between strains of Escherichia coli in the chicken digestive system].
    Guillot JF; Boucaud JL
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):655-9. PubMed ID: 3054742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model.
    Perrin-Guyomard A; Poul JM; Corpet DE; Sanders P; Fernández AH; Bartholomew M
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):151-60. PubMed ID: 15963836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial antibiotic resistance: frequency of gentamicin-resistant strains of Escherichia coli in the fecal microflora of commercial turkeys.
    Dubel JR; Zink DL; Kelley LM; Naqi SA; Renshaw HW
    Am J Vet Res; 1982 Oct; 43(10):1786-9. PubMed ID: 6756224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of methods to assess the effect of antimicrobial residues on the human gut flora.
    Corpet DE
    Vet Microbiol; 1993 Jun; 35(3-4):199-212. PubMed ID: 8212507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution and diversity of conjugative plasmids among some multiple antibiotic resistant E.coli strains isolated from river waters].
    Cernat R; Lazăr V; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):147-53. PubMed ID: 15085604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The occurrence of drug-resistant colicinogenic E coli strains in the fecal flora of calves. 1st communication. Frequency under therapeutic and nutritive antibiotic dosage].
    Gedek B; Schäl E
    Zentralbl Veterinarmed B; 1976 Mar; 23(2):89-104. PubMed ID: 773054
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model.
    Perrin-Guyomard A; Poul JM; Laurentie M; Sanders P; Fernández AH; Bartholomew M
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):66-78. PubMed ID: 16563587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimum antibiotic levels for selecting a resistance plasmid in a gnotobiotic animal model.
    Corpet DE; Lumeau S; Corpet F
    Antimicrob Agents Chemother; 1989 Apr; 33(4):535-40. PubMed ID: 2658794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extrachromosomal antibiotic resistance of the intestinal bacterial flora. II. The role of resistance acquired by endogenous intestinal bacterial flora (author's transl)].
    Michel-Briand Y
    Nouv Presse Med; 1977 Dec; 6(41):3851-5. PubMed ID: 593869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to antibiotics in the normal flora of animals.
    Sørum H; Sunde M
    Vet Res; 2001; 32(3-4):227-41. PubMed ID: 11432415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carriage of antimicrobial resistant Escherichia coli in adult intestinal flora.
    Newman MJ; Seidu A
    West Afr J Med; 2002; 21(1):48-50. PubMed ID: 12081343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic residues and drug resistance in human intestinal flora.
    Corpet DE
    Antimicrob Agents Chemother; 1987 Apr; 31(4):587-93. PubMed ID: 3300533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Kutter E; Sarker S; Brüssow H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment studies of E. coli host-vector systems.
    Levy SB; Marshall B
    Recomb DNA Tech Bull; 1981 Sep; 4(3):91-8. PubMed ID: 6269154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.